Moxifloxacin
Moxifloxacin, STRENZA PLUS, VIGAMOX
Fluoroquinolone Antibacterial
NADAC/unit
$1.7260
No Shortage
Tier 1: 63.8%
PA Req: 10.3%
20 Manufacturers
21 ANDAs
vs. brand Moxifloxacin: Generic saves up to 83% per unit
Active Shortages
2025-10-29 Discontinuation of the manufacture of the drug, Fresenius Kabi USA, LLC
Generic Manufacturers
ALEMBIC PHARMACEUTICALS LTDAPOTEX INCAUROBINDO PHARMA LTDCHARTWELL RX SCIENCES LLCCROSSMEDIKA SADR REDDYS LABORATORIES LTDEUGIA PHARMA SPECIALITIES LTDFRESENIUS KABI USA LLCGLAND PHARMA LTDHARROW EYE LLCHETERO LABS LTD UNIT VLUPIN LTDMACLEODS PHARMACEUTICALS LTDMANKIND PHARMA LTDMSN LABORATORIES PRIVATE LTDMYLAN LABORATORIES LTDREGCON HOLDINGS LLCSOMERSET THERAPEUTICS LLCSUNSHINE LAKE PHARMA CO LTDTEVA PHARMACEUTICALS USATORRENT PHARMACEUTICALS LTDUPSHER SMITH LABORATORIES LLC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.